iANTHUS CAPITAL HOLDINGS (ITHUF) Interest Expenses (2020 - 2026)
iANTHUS CAPITAL HOLDINGS's (ITHUF) quarterly Interest Expenses came in at $4.1 million in Q1 2026, down 1.61% year-on-year from $4.2 million in Q1 2025, and down 0.72% quarter-over-quarter from $4.2 million in Q4 2025.
iANTHUS CAPITAL HOLDINGS (ITHUF) Interest Expenses (2020 - 2026) Analysis & Trends
iANTHUS CAPITAL HOLDINGS has disclosed Interest Expenses across 7 years of filings, most recently posting $4.1 million for Q1 2026.
- Interest Expenses for Q1 2026 came in at $4.1 million, down 1.61% year-over-year; the trailing twelve-month figure through Mar 2026 was $16.5 million (down 4.06% YoY), and the FY2025 annual result was $16.6 million, down 3.32% from the prior year.
- Interest Expenses came in at $4.1 million for Q1 2026 at iANTHUS CAPITAL HOLDINGS, down from $4.2 million in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $5.8 million in Q2 2022 to a low of $400000.0 in Q1 2022.
- The 5-year median for Interest Expenses is $4.1 million (2026), against an average of $3.9 million.
- Peak annual rise in Interest Expenses reached 1348.25% in 2022, while the deepest fall reached 42.35% in 2022.
- iANTHUS CAPITAL HOLDINGS's Interest Expenses stood at $3.5 million in 2022, then gained by 16.52% to $4.1 million in 2023, then rose by 8.08% to $4.4 million in 2024, then dropped by 5.74% to $4.2 million in 2025, then declined by 0.72% to $4.1 million in 2026.
- The last three Interest Expenses figures came in at $4.1 million (Q1 2026), $4.2 million (Q4 2025), and $4.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | - |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 62.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 3.00 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 57.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 20.89 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 4.86 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | - |
| 10 | iANTHUS CAPITAL HOLDINGS | - | - | 15.92 Mn | 4.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.14 Mn |
| Mar 31, 2026 | 4.14 Mn |
| Dec 31, 2025 | 4.17 Mn |
| Dec 31, 2025 | 4.17 Mn |
| Sep 30, 2025 | 4.15 Mn |
| Sep 30, 2025 | 4.15 Mn |
| Jun 30, 2025 | 4.07 Mn |
| Jun 30, 2025 | 4.07 Mn |
| Mar 31, 2025 | 4.21 Mn |
| Mar 31, 2025 | 4.21 Mn |
| Dec 31, 2024 | 4.43 Mn |
| Dec 31, 2024 | 4.43 Mn |
| Sep 30, 2024 | 4.35 Mn |
| Sep 30, 2024 | 4.35 Mn |
| Jun 30, 2024 | 4.24 Mn |
| Jun 30, 2024 | 4.24 Mn |
| Mar 31, 2024 | 4.15 Mn |
| Mar 31, 2024 | 4.15 Mn |
| Dec 31, 2023 | 4.10 Mn |
| Dec 31, 2023 | 4.10 Mn |